These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 32402755)

  • 1. Protective efficacy of peptides from Plasmodium vivax circumsporozoite protein.
    Atcheson E; Reyes-Sandoval A
    Vaccine; 2020 Jun; 38(27):4346-4354. PubMed ID: 32402755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A universal vaccine candidate against Plasmodium vivax malaria confers protective immunity against the three PvCSP alleles.
    Gimenez AM; Salman AM; Marques RF; López-Camacho C; Harrison K; Kim YC; Janse CJ; Soares IS; Reyes-Sandoval A
    Sci Rep; 2021 Sep; 11(1):17928. PubMed ID: 34504134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a Plasmodium berghei transgenic parasite expressing the full-length Plasmodium vivax circumsporozoite VK247 protein for testing vaccine efficacy in a murine model.
    Mizutani M; Fukumoto S; Soubeiga AP; Soga A; Iyori M; Yoshida S
    Malar J; 2016 Apr; 15(1):251. PubMed ID: 27129682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tailoring a Plasmodium vivax Vaccine To Enhance Efficacy through a Combination of a CSP Virus-Like Particle and TRAP Viral Vectors.
    Atcheson E; Bauza K; Salman AM; Alves E; Blight J; Viveros-Sandoval ME; Janse CJ; Khan SM; Hill AVS; Reyes-Sandoval A
    Infect Immun; 2018 Sep; 86(9):. PubMed ID: 29986894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic polymorphism and natural selection of circumsporozoite protein in Myanmar Plasmodium vivax.
    Võ TC; Lê HG; Kang JM; Moe M; Naw H; Myint MK; Lee J; Sohn WM; Kim TS; Na BK
    Malar J; 2020 Sep; 19(1):303. PubMed ID: 32883283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A two-dose viral-vectored
    Yamamoto Y; Fabbri C; Okuhara D; Takagi R; Kawabata Y; Katayama T; Iyori M; Hasyim AA; Sakamoto A; Mizukami H; Shida H; Lopes S; Yoshida S
    Front Immunol; 2024; 15():1372584. PubMed ID: 38745665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity of a prime-boost vaccine containing the circumsporozoite proteins of Plasmodium vivax in rodents.
    Teixeira LH; Tararam CA; Lasaro MO; Camacho AG; Ersching J; Leal MT; Herrera S; Bruna-Romero O; Soares IS; Nussenzweig RS; Ertl HC; Nussenzweig V; Rodrigues MM
    Infect Immun; 2014 Feb; 82(2):793-807. PubMed ID: 24478093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of a Genetically Modified Chimeric
    Miyazaki Y; Marin-Mogollon C; Imai T; Mendes AM; van der Laak R; Sturm A; Geurten FJA; Miyazaki S; Chevalley-Maurel S; Ramesar J; Kolli SK; Kroeze H; van Schuijlenburg R; Salman AM; Wilder BK; Reyes-Sandoval A; Dechering KJ; Prudêncio M; Janse CJ; Khan SM; Franke-Fayard B
    Front Cell Infect Microbiol; 2020; 10():591046. PubMed ID: 33392104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rational development of a protective P. vivax vaccine evaluated with transgenic rodent parasite challenge models.
    Salman AM; Montoya-Díaz E; West H; Lall A; Atcheson E; Lopez-Camacho C; Ramesar J; Bauza K; Collins KA; Brod F; Reis F; Pappas L; González-Cerón L; Janse CJ; Hill AVS; Khan SM; Reyes-Sandoval A
    Sci Rep; 2017 Apr; 7():46482. PubMed ID: 28417968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccine Containing the Three Allelic Variants of the
    Gimenez AM; Lima LC; Françoso KS; Denapoli PMA; Panatieri R; Bargieri DY; Thiberge JM; Andolina C; Nosten F; Renia L; Nussenzweig RS; Nussenzweig V; Amino R; Rodrigues MM; Soares IS
    Front Immunol; 2017; 8():1275. PubMed ID: 29075260
    [No Abstract]   [Full Text] [Related]  

  • 11. Phase 1/2a Trial of Plasmodium vivax Malaria Vaccine Candidate VMP001/AS01B in Malaria-Naive Adults: Safety, Immunogenicity, and Efficacy.
    Bennett JW; Yadava A; Tosh D; Sattabongkot J; Komisar J; Ware LA; McCarthy WF; Cowden JJ; Regules J; Spring MD; Paolino K; Hartzell JD; Cummings JF; Richie TL; Lumsden J; Kamau E; Murphy J; Lee C; Parekh F; Birkett A; Cohen J; Ballou WR; Polhemus ME; Vanloubbeeck YF; Vekemans J; Ockenhouse CF
    PLoS Negl Trop Dis; 2016 Feb; 10(2):e0004423. PubMed ID: 26919472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant Plasmodium vivax circumsporozoite surface protein allelic variants: antibody recognition by individuals from three communities in the Brazilian Amazon.
    Soares IF; López-Camacho C; Rodrigues-da-Silva RN; da Silva Matos A; de Oliveira Baptista B; Totino PRR; de Souza RM; Harrison K; Gimenez AM; de Freitas EO; Kim YC; Oliveira-Ferreira J; Daniel-Ribeiro CT; Reyes-Sandoval A; Pratt-Riccio LR; Lima-Junior JDC
    Sci Rep; 2020 Aug; 10(1):14020. PubMed ID: 32820195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of Multifunctional Broadly Reactive T Cell Responses by a Plasmodium vivax Circumsporozoite Protein Recombinant Chimera.
    Cabrera-Mora M; Fonseca JA; Singh B; Oliveira-Ferreira J; Lima-Junior Jda C; Calvo-Calle JM; Moreno A
    Infect Immun; 2015 Sep; 83(9):3749-61. PubMed ID: 26169267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-clinical toxicity and immunogenicity evaluation of a Plasmodium vivax malaria vaccine using Poly-ICLC (Hiltonol®) as adjuvant.
    Marques RF; Gimenez AM; Caballero O; Simpson A; Salazar AM; Amino R; Godin S; Gazzinelli RT; Soares IS
    Vaccine; 2024 Apr; 42(9):2394-2406. PubMed ID: 38448321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prime-boost vaccination with recombinant protein and adenovirus-vector expressing Plasmodium vivax circumsporozoite protein (CSP) partially protects mice against Pb/Pv sporozoite challenge.
    de Camargo TM; de Freitas EO; Gimenez AM; Lima LC; de Almeida Caramico K; Françoso KS; Bruna-Romero O; Andolina C; Nosten F; Rénia L; Ertl HCJ; Nussenzweig RS; Nussenzweig V; Rodrigues MM; Reyes-Sandoval A; Soares IS
    Sci Rep; 2018 Jan; 8(1):1118. PubMed ID: 29348479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chimeric Plasmodium falciparum parasites expressing Plasmodium vivax circumsporozoite protein fail to produce salivary gland sporozoites.
    Marin-Mogollon C; van Pul FJA; Miyazaki S; Imai T; Ramesar J; Salman AM; Winkel BMF; Othman AS; Kroeze H; Chevalley-Maurel S; Reyes-Sandoval A; Roestenberg M; Franke-Fayard B; Janse CJ; Khan SM
    Malar J; 2018 Aug; 17(1):288. PubMed ID: 30092798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population genetic structure of the Plasmodium vivax circumsporozoite protein (Pvcsp) in Sri Lanka.
    Dias S; Wickramarachchi T; Sahabandu I; Escalante AA; Udagama PV
    Gene; 2013 Apr; 518(2):381-7. PubMed ID: 23333606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the immune responses induced by soluble and particulate Plasmodium vivax circumsporozoite vaccine candidates formulated in AS01 in rhesus macaques.
    Vanloubbeeck Y; Pichyangkul S; Bayat B; Yongvanitchit K; Bennett JW; Sattabongkot J; Schaecher K; Ockenhouse CF; Cohen J; Yadava A;
    Vaccine; 2013 Dec; 31(52):6216-24. PubMed ID: 24144477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-lasting humoral and cellular immune responses elicited by immunization with recombinant chimeras of the Plasmodium vivax circumsporozoite protein.
    Almeida AP; Dias MO; Vieira Cde A; Chávez-Olórtegui C; Gazzineli RT; Rodrigues MM; Fujiwara RT; Bruna-Romero O
    Vaccine; 2014 Apr; 32(19):2181-7. PubMed ID: 24582631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective Malaria Vaccine in Mice Based on the
    Marques RF; Gimenez AM; Aliprandini E; Novais JT; Cury DP; Watanabe IS; Dominguez MR; Silveira ELV; Amino R; Soares IS
    Vaccines (Basel); 2020 Apr; 8(2):. PubMed ID: 32325874
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.